TP53 and cancer: Frequent mutations of the TP53 gene in cancer (notably in 96% of HGSOC tumors) could lead to de-repression of oncogenic DREAM target genes, such as Survivin (BIRC5), CDC25C, and PLK1 (19, 40, 42, 43).